# SymbioCellTech, LLC: Form D filings

SymbioCellTech, LLC, a biotechnology company in Salt Lake City, UT, filed 4 Form D notices with the SEC between 2014 and 2017. The latest, on August 28, 2017, reports $286,050 sold of a $2 million offering to 3 investors.

Find out what SymbioCellTech, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20SymbioCellTech%2C%20LLC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=SymbioCellTech%2C%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Fsymbiocelltech-llc-1575304)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20SymbioCellTech%2C%20LLC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=SymbioCellTech%2C%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Fsymbiocelltech-llc-1575304)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Utah](https://specstream.ai/data/form-d/state/utah): 660 rows, by operating companies, filed since November 1, 2024, $33, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/utah
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 615 ARAPEEN, SUITE 210, Salt Lake City, UT, 84108
- Phone: (801) 503-3990
- Industry: Biotechnology
- Entity type: Limited Liability Company
- Incorporated in: Utah
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1575304

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Aug 28, 2017 | New notice | $2,000,000 | $286,050 | $1,713,950 | 3 | Aug 14, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1575304/000157530417000001/0001575304-17-000001-index.htm) |
| Jun 30, 2016 | New notice | $2,000,000 | $1,912,600 | $87,400 | 4 | Jun 20, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1575304/000157530416000001/0001575304-16-000001-index.htm) |
| Jun 5, 2014 | Amendment | $7,000,000 | $2,555,000 | $4,445,000 | 7 | Mar 17, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1575304/000157530414000003/0001575304-14-000003-index.htm) |
| Mar 21, 2014 | New notice | $2,000,000 | $200,000 | $1,800,000 | 2 | Mar 17, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1575304/000157530414000002/0001575304-14-000002-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Allen Gardner | Director |  |
| Phil Holmes | Director |  |
| Axel Zander | Director, Promoter |  |
| Susan McKeever | Executive Officer, Director |  |
| Robert Maddock, LLC | Director |  |
| Christof Westenfelder | Executive Officer, Director, Promoter |  |
| Anna Gooch | Executive Officer, Director |  |
| George Reiss | Director |  |

## Other biotechnology companies in Utah that filed recently

- [Life Impact Partners 14 LLC](https://specstream.ai/data/form-d/company/life-impact-partners-14-llc-2163022) offering · Nov 9, 2026
- [Life Impact Partners 15 LLC](https://specstream.ai/data/form-d/company/life-impact-partners-15-llc-2163019) offering · Nov 9, 2026
- [Life Impact Partners 7 LLC](https://specstream.ai/data/form-d/company/life-impact-partners-7-llc-2163024) offering · Nov 6, 2026
- [Life Impact Partners 6 LLC](https://specstream.ai/data/form-d/company/life-impact-partners-6-llc-2163017) offering · Nov 6, 2026
- [Life Impact Partners 3 LLC](https://specstream.ai/data/form-d/company/life-impact-partners-3-llc-2162995) offering · Nov 6, 2026
- [Life Impact Partners 5 LLC](https://specstream.ai/data/form-d/company/life-impact-partners-5-llc-2162994) offering · Nov 6, 2026
- [Life Impact Partners 4 LLC](https://specstream.ai/data/form-d/company/life-impact-partners-4-llc-2162993) offering · Nov 6, 2026
- [Life Impact Partners 2 LLC](https://specstream.ai/data/form-d/company/life-impact-partners-2-llc-2162992) offering · Nov 6, 2026
- [Life Impact Partners 8 LLC](https://specstream.ai/data/form-d/company/life-impact-partners-8-llc-2162973) offering · Nov 6, 2026
- [Life Impact Partners 1 LLC](https://specstream.ai/data/form-d/company/life-impact-partners-1-llc-2154209) offering · Oct 22, 2026
- [3Helix, Inc.](https://specstream.ai/data/form-d/company/3helix-inc-2001622) $7.8 million · Sep 21, 2026
- [Halia Therapeutics, Inc.](https://specstream.ai/data/form-d/company/halia-therapeutics-inc-1829255) $3.5 million · Aug 31, 2026
- [Paterna BioSciences HoldCo Inc.](https://specstream.ai/data/form-d/company/paterna-biosciences-holdco-inc-1989862) $6.3 million · Aug 12, 2026

[Every Form D from the week of Aug 28, 2017](https://specstream.ai/data/form-d/week/2017-08-28) · [All recent filings in Utah](https://specstream.ai/data/form-d/state/utah) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what SymbioCellTech, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).